78
Participants
Start Date
April 18, 2024
Primary Completion Date
October 24, 2024
Study Completion Date
November 23, 2024
Ropivacaine 0.5% Injectable Solution
30 mL Ropivacaine 5 mg/mL (= 150 mg Ropivacaine)
Lidocaine epinephrine
20 mL Ropivacaine 5 mg/mL + 10 mL Lidocaine-Epinephrine (20 mg + 5 μg) / ml (= 100 mg Ropivacaine + 200 mg Lidocaine)
Ropivacaine 0.75% Injectable Solution
20 mL Ropivacaine 7,5 mg/mL + 10 mL Lidocaine-Epinephrine (20 mg + 5 μg)/mL (= 150 mg Ropivacaine + 200 mg Lidocaine)
Nordsjælland Hospital, Hillerød
Nordsjaellands Hospital
OTHER